Search Results - "KOHLER, JILLIAN CLARE"

Refine Results
  1. 1

    An exploration of anti-corruption and health in international organizations by Bowra, Andrea, Saeed, Gul, Gorodensky, Ariel, Kohler, Jillian Clare

    Published in PloS one (02-08-2022)
    “…Corruption is a global wicked problem that threatens the achievement of health, social and economic development goals, including Sustainable Development Goal #…”
    Get full text
    Journal Article
  2. 2

    The risk of corruption in public pharmaceutical procurement: how anti-corruption, transparency and accountability measures may reduce this risk by Kohler, Jillian Clare, Dimancesco, Deirdre

    Published in Global health action (03-02-2020)
    “…Background: The goal of the public procurement of pharmaceuticals is to purchase sufficient quantities of high-quality pharmaceuticals at cost-effective prices…”
    Get full text
    Journal Article
  3. 3

    Exploring anti-corruption, transparency, and accountability in the World Health Organization, the United Nations Development Programme, the World Bank Group, and the Global Fund to Fight AIDS, Tuberculosis and Malaria by Kohler, Jillian Clare, Bowra, Andrea

    Published in Globalization and health (20-10-2020)
    “…Corruption is recognized by the global community as a threat to development generally and to achieving health goals, such as the United Nations Sustainable…”
    Get full text
    Journal Article
  4. 4

    Can a multistakeholder initiative improve transparency and accountability in the pharmaceutical sector? Evidence from the Medicines Transparency Alliance by Vian, Taryn, PhD, Kohler, Jillian Clare, PhD, Dimancesco, Deirdre, MBA, Forte, Gilles, PhD

    Published in The Lancet global health (01-04-2017)
    “…Abstract Background Access to affordable quality essential medicines is crucial if universal health coverage and the Sustainable Development Goals are to be…”
    Get full text
    Journal Article
  5. 5

    The Urgent Need for Transparent and Accountable Procurement of Medicine and Medical Supplies in Times of COVID-19 Pandemic by Kohler, Jillian Clare, Wright, Tom

    “…Abstract The COVID-19 pandemic has unleashed unprecedented and complex public policy issues. One that has emerged as a challenge for many countries globally is…”
    Get full text
    Journal Article
  6. 6

    The success rate of new drug development in clinical trials: Crohn's disease by Parker, Jayson L, Clare Kohler, Jillian

    “…To determine the risk of drug failure during clinical trial testing in Crohn's disease and determine what steps can be taken to improve outcomes. This is the…”
    Get full text
    Journal Article
  7. 7

    Legislating for Good Governance in the Pharmaceutical Sector through UN Convention Against Corruption (UNCAC) Compliance by Wong, Anna, Perehudoff, Katrina, Kohler, Jillian Clare

    Published in Global public health (2024)
    “…Pharmaceutical sector corruption undermines patient access to medicines by diverting public funds for private gain and exacerbating health inequities This…”
    Get full text
    Journal Article
  8. 8

    I Know It When I See It: The Challenges of Addressing Corruption in Health Systems Comment on "We Need to Talk About Corruption in Health Systems" by Kohler, Jillian Clare

    “…In this commentary, I argue that corruption in health systems is a critical and legitimate area for research in order to strengthen health policy goals. This…”
    Get full text
    Journal Article
  9. 9

    Assessing national governance of medicine promotion: an exploratory study in Ghana to trial a structured set of indicators by McLean, Marcia, Kohler, Jillian Clare, Edwards, Danny

    “…Two billion people worldwide, predominantly in low- and middle-income countries, cannot consistently access required essential medications, thus affecting…”
    Get full text
    Journal Article
  10. 10

    Canada's neglected tropical disease research network: who's in the core-who's on the periphery? by Phillips, Kaye, Kohler, Jillian Clare, Pennefather, Peter, Thorsteinsdottir, Halla, Wong, Joseph

    Published in PLoS neglected tropical diseases (01-12-2013)
    “…This study designed and applied accessible yet systematic methods to generate baseline information about the patterns and structure of Canada's neglected…”
    Get full text
    Journal Article
  11. 11

    The Use of Cost-Effectiveness Analysis for Pediatric Immunization in Developing Countries by GAUVREAU, CINDY LOW, UNGAR, WENDY J., KÖHLER, JILLIAN CLARE, ZLOTKIN, STANLEY

    Published in The Milbank quarterly (01-12-2012)
    “…Context: Developing countries face critical choices for introducing needed, effective, but expensive new vaccines, especially given the accelerated need to…”
    Get full text
    Journal Article
  12. 12

    An examination of pharmaceutical systems in severely disrupted countries by Kohler, Jillian Clare, Pavignani, Enrico, Michael, Markus, Ovtcharenko, Natalia, Murru, Maurizio, Hill, Peter S

    Published in BMC international health and human rights (06-12-2012)
    “…This research assesses informal markets that dominate pharmaceutical systems in severely disrupted countries and identifies areas for further investigation…”
    Get full text
    Journal Article
  13. 13

    Global health and human rights in the time of COVID-19: Response, restrictions, and legitimacy by Forman, Lisa, Kohler, Jillian Clare

    Published in Journal of human rights (19-10-2020)
    “…Policy responses to the COVID-19 pandemic have impacted a range of human rights, with the pandemic being used to justify police violence, authoritarian power…”
    Get full text
    Journal Article
  14. 14

    Interconnected influence: Unraveling purdue pharmaceutical's role in the global response to the opioid crisis by Bowra, Andrea, Perez-Brumer, Amaya, Forman, Lisa, Kohler, Jillian Clare

    Published in The International journal of drug policy (01-11-2024)
    “…The global pharmaceutical industry has a long history of prioritizing profits over public health through widespread practices such as price gouging, deceptive…”
    Get full text
    Journal Article
  15. 15

    Civil society participation in the health system: the case of Brazil's Health Councils by Martinez, Martha Gabriela, Kohler, Jillian Clare

    Published in Globalization and health (26-10-2016)
    “…Brazil created Health Councils to bring together civil society groups, heath professionals, and government officials in the discussion of health policies and…”
    Get full text
    Journal Article
  16. 16

    The Global Wicked Problem of Corruption and Its Risks for Access to HIV/AIDS Medicines by Kohler, Jillian Clare, Chang Pico, Tomas, Vian, Taryn, Mackey, Tim K.

    Published in Clinical pharmacology and therapeutics (01-12-2018)
    “…We discuss how corruption affects access to antiretroviral therapies (ARVs) globally. Recent cases of theft of ARVs, collusion, and manipulation in procurement…”
    Get full text
    Journal Article
  17. 17

    Why the MDGs need good governance in pharmaceutical systems to promote global health by Kohler, Jillian Clare, Mackey, Tim Ken, Ovtcharenko, Natalia

    Published in BMC public health (21-01-2014)
    “…Corruption in the health sector can hurt health outcomes. Improving good governance can in turn help prevent health-related corruption. We understand good…”
    Get full text
    Journal Article
  18. 18

    The disease of corruption: views on how to fight corruption to advance 21st century global health goals by Mackey, Tim K, Kohler, Jillian Clare, Savedoff, William D, Vogl, Frank, Lewis, Maureen, Sale, James, Michaud, Joshua, Vian, Taryn

    Published in BMC medicine (29-09-2016)
    “…Corruption has been described as a disease. When corruption infiltrates global health, it can be particularly devastating, threatening hard gained improvements…”
    Get full text
    Journal Article
  19. 19

    Corporate social responsibility to improve access to medicines: the case of Brazil by Thorsteinsdóttir, Halla, Ovtcharenko, Natasha, Kohler, Jillian Clare

    Published in Globalization and health (21-02-2017)
    “…Access to medicines and the development of a strong national pharmaceutical industry are two longstanding pillars of health policy in Brazil. This is reflected…”
    Get full text
    Journal Article
  20. 20

    "To patent or not to patent? the case of Novartis' cancer drug Glivec in India" by Gabble, Ravinder, Kohler, Jillian Clare

    Published in Globalization and health (06-01-2014)
    “…Glivec (imatinib mesylate), produced by the pharmaceutical company Novartis, is prescribed in the case of chronic myeloid leukemia, one of the most common…”
    Get full text
    Journal Article